Topical Therapy in Psoriasis Treatment

What is the threshold PASI score for severe psoriasis?

Which therapy is recommended for chronic plaque-type psoriasis with mild severity (BSA < 10% and PASI < 10)?

Which systemic therapy is NOT recommended for chronic plaque-type psoriasis with moderate severity (BSA > 10% and PASI > 10)?

Which biologic therapy is indicated for the treatment of psoriasis as per the provided text?

What measures will become a part of everyday practice in assessing psoriasis severity and treatment response?

Which cells are responsible for the activation of T cells in psoriasis?

Which type of T cells are the principal 'effector' T cells in psoriatic plaques?

What is the primary purpose of adalimumab in the maintenance of psoriasis remission?

Which subtype of psoriasis is a contraindication for biologics?

What is a common feature of psoriatic arthritis associated with psoriasis?

What is the main hypothesis regarding the development of psoriasis?

What drives inflammation and keratinocyte hyperplasia in psoriatic plaque?

Which comorbidity is not commonly associated with psoriasis?

What type of drugs are biologics used to treat in psoriasis patients?

What initiates the activation of T cells in the skin of psoriasis patients?

What is the principle behind sequential therapy of psoriasis using Methotrexate (MTX), Cyclosporine (CyA), and Acitretin?

Which therapy combines both topical and systemic treatments for psoriasis?

What is the mechanism of action of Methotrexate (MTX) in the treatment of psoriasis?

Which oral systemic therapy for psoriasis is a folic acid antagonist that inhibits DNA synthesis and cell replication?

Which therapy is known for its selective/targeted approach in the treatment of psoriasis?

Which cytokines are key in the development of Th1 and Th17 cells in psoriasis?

Which of the following cells promote the formation of psoriatic skin lesions by producing cytokines such as IL-17, IL-22, IFN-g, and TNF-a?

What are the heterodimers with a common subunit that is a potential target for therapeutic intervention in psoriasis?

Which type of cells are responsible for the differentiation and expansion of T cell populations of the Th1 and Th17 subtype in psoriasis?

Which cytokines are produced by Th1 and Th17 cells to promote the formation of psoriatic skin lesions?

What is the first-line topical therapy for psoriasis in cases with moderate body surface area (BSA > 10%) and Psoriasis Area Severity Index (PASI) > 10?

What is the most suitable topical therapy for psoriasis in sensitive areas like the face and groin?

Which topical therapy should be avoided in pregnant patients due to its unsuitability?

What is the recommended combination therapy for scalp psoriasis with synergistic activity on a molecular level?

Which topical therapy should be used with caution in children due to potential toxic effects such as nausea, vomiting, and tinnitus?

What is the recommended treatment for extensive chronic plaque psoriasis in the elderly or infirm?

What is the threshold body surface area affected (BSA) that indicates the need for systemic therapy in psoriasis?

Which topical therapy is effective in the short term with a 2 point improvement on a 12 point severity scale?

What is the primary consideration for the choice of topical treatment for psoriasis?

What is the indicated PASI score for severe psoriasis requiring systemic therapy?

Which therapy should not be used during pregnancy or lactation?

What is a common reason for poor adherence to topical therapy in psoriasis?

Which of the following is NOT an indication for systemic therapy of psoriasis?

Which topical therapy has no scientific evidence indicating its carcinogenicity in over-the-counter products?

Which topical therapy is a vitamin D analogue?